{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:48:28Z","timestamp":1786992508346,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jhep.2008.12.030","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T05:49:40Z","timestamp":1236318580000},"page":"1010-1018","source":"Crossref","is-referenced-by-count":50,"title":["Gilbert\u2019s syndrome and hyperbilirubinemia in protease inhibitor therapy \u2013 An extended haplotype of genetic variants increases risk in indinavir treatment"],"prefix":"10.1016","volume":"50","author":[{"given":"Tim O.","family":"Lankisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Ehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wehmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kalthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2008.12.030_bib1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.12.030_bib2","first-page":"6921","article-title":"Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis","volume":"60","author":"Ando","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2008.12.030_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan","volume":"22","author":"Innocenti","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2008.12.030_bib4","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.21361","article-title":"Gilbert\u2019s disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype","volume":"44","author":"Lankisch","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.12.030_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/dmd.105.007633","article-title":"Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of cyp2c8: implications for drug\u2013drug interactions","volume":"34","author":"Ogilvie","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2008.12.030_bib6","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.1073\/pnas.231140698","article-title":"Mechanism of indinavir-induced hyperbilirubinemia","volume":"98","author":"Zucker","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2008.12.030_bib7","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.3748\/wjg.v11.i21.3250","article-title":"Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes","volume":"11","author":"Tang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.12.030_bib8","first-page":"950","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans","volume":"60","author":"Guillemette","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2008.12.030_bib9","first-page":"711","article-title":"Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels","volume":"10","author":"Guillemette","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhep.2008.12.030_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/B:BREA.0000025419.26423.b8","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer","volume":"85","author":"Adegoke","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jhep.2008.12.030_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2217\/14622416.9.6.703","article-title":"Pharmacogenetics of Gilbert\u2019s syndrome","volume":"9","author":"Strassburg","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jhep.2008.12.030_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1055-9965.EPI-03-0070","volume":"13","author":"Fang","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhep.2008.12.030_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1055-9965.EPI-07-2517","article-title":"Gilbert\u2019s syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk","volume":"17","author":"Lankisch","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhep.2008.12.030_bib14","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","article-title":"In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2008.12.030_bib15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/466531","article-title":"Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia","volume":"192","author":"Rotger","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2008.12.030_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrd2411","article-title":"The way forward in HCV treatment-finding the right path","volume":"6","author":"Manns","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2008.12.030_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00204-008-0314-x","article-title":"Family 1 uridine-5\u2019-diphosphate glucuronosyltransferases (UGT1A): from Gilbert\u2019s syndrome to genetic organization and variability","volume":"82","author":"Strassburg","year":"2008","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jhep.2008.12.030_bib18","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","article-title":"Polymorphic gene expression and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine","volume":"275","author":"Strassburg","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2008.12.030_bib19","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.273.15.8719","article-title":"Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8","volume":"273","author":"Strassburg","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2008.12.030_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0026-895X(24)13065-9","article-title":"Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium","volume":"54","author":"Strassburg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2008.12.030_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/0264-6021:3380489","article-title":"Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus","volume":"338","author":"Strassburg","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2008.12.030_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0016-5085(99)70239-8","article-title":"UDP-glucuronosyltransferase activity in human liver and colon","volume":"116","author":"Strassburg","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.12.030_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhep.2005.09.011","article-title":"Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin","volume":"44","author":"Ellis","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.12.030_bib24","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1074\/jbc.271.7.3952","article-title":"Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex","volume":"271","author":"Emi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2008.12.030_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.taap.2008.02.020","article-title":"Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene","volume":"230","author":"Erichsen","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2008.12.030_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/dmd.106.012203","article-title":"Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1alpha","volume":"35","author":"Gardner-Stephen","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2008.12.030_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FPC.0b013e32801112b5","article-title":"Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4alpha","volume":"17","author":"Gardner-Stephen","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jhep.2008.12.030_bib28","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1074\/jbc.M610790200","article-title":"Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice","volume":"282","author":"Yueh","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2008.12.030_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human UDP-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2008.12.030_bib30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/hep.20131","article-title":"Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4","volume":"39","author":"Ehmer","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.12.030_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008571-200010000-00006","article-title":"Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene","volume":"10","author":"Guillemette","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jhep.2008.12.030_bib32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/gut.50.6.851","article-title":"Polymorphisms of the UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.12.030_bib33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1124\/mol.104.007146","article-title":"Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene","volume":"67","author":"Lankisch","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2008.12.030_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.tpj.6500335","article-title":"Haplotype structures of the UGT1A gene complex in a Japanese population","volume":"6","author":"Saeki","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jhep.2008.12.030_bib35","first-page":"241","article-title":"La cholamae simple familiale","volume":"21","author":"Gilbert","year":"1901","journal-title":"Sem Med"},{"key":"10.1016\/j.jhep.2008.12.030_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0021-9258(17)35280-8","article-title":"Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells","volume":"266","author":"Ritter","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2008.12.030_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1008438109725","article-title":"UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan","volume":"9","author":"Ando","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2008.12.030_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.fpc.0000197465.14340.d4","article-title":"Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir","volume":"16","author":"Boyd","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jhep.2008.12.030_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0090-9556(25)06530-4","article-title":"Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine","volume":"23","author":"Balani","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2008.12.030_bib40","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/1078-0432.CCR-05-0703","article-title":"Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes","volume":"11","author":"Yong","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2008.12.030_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/humu.9432","article-title":"Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus","volume":"27","author":"Thomas","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jhep.2008.12.030_bib42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0168-8278(00)80268-8","article-title":"Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene [In Process Citation]","volume":"33","author":"Raijmakers","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.12.030_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/gut.17.8.581","article-title":"Alteration of drug metabolism in Gilbert\u2019s syndrome","volume":"17","author":"Carulli","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.12.030_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-197904030-00004","article-title":"Gilbert\u2019s syndrome and drug metabolism","volume":"4","author":"Macklon","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhep.2008.12.030_bib45","first-page":"434","article-title":"Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert\u2019s syndrome after repeated doses","volume":"23","author":"Okolicsanyi","year":"1985","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.jhep.2008.12.030_bib46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0016-5085(19)33296-2","article-title":"Defective bromosulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert\u2019s syndrome)","volume":"63","author":"Berk","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.12.030_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0016-5085(76)80151-5","article-title":"Abnormal hepatic transport of indocyanine green in Gilbert\u2019s syndrome","volume":"70","author":"Martin","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.12.030_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cbi.2004.08.008","article-title":"Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia","volume":"150","author":"Campbell","year":"2004","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2008.12.030_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.qai.0000225013.53568.69","article-title":"Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study","volume":"42","author":"Anderson","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jhep.2008.12.030_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/14656566.8.7.957","article-title":"Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?","volume":"8","author":"Boyd","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jhep.2008.12.030_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1517\/17425255.3.3.347","article-title":"Indinavir\/ritonavir remains an important component of HAART for the treatment of HIV\/AIDS, particularly in resource-limited settings","volume":"3","author":"Cressey","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jhep.2008.12.030_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00008571-199502000-00005","article-title":"(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7","volume":"5","author":"Patel","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jhep.2008.12.030_bib53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.56.1.226","article-title":"Human and rat liver UDP-glucuronosyltransferases are targets of ketoprofen acylglucuronide","volume":"56","author":"Terrier","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2008.12.030_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.clpt.6100330","article-title":"Lopinavir\u2013ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi\u2019s sarcoma","volume":"83","author":"Corona","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2008.12.030_bib55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/clpt.2008.106","article-title":"The Effect of Atazanavir and Atazanavir\/Ritonavir on UDP-Glucuronosyltransferase Using Lamotrigine as a Phenotypic Probe","volume":"84","author":"Burger","year":"2008","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:59:10Z","timestamp":1738961950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827809000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0168827809000877"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2008.12.030","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}